Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Fanhua Subsidiary Signs Strategic Cooperation Agreement With Shanghai Biotecan Pharmaceuticals

Author: Benzinga Newsdesk | September 06, 2024 06:32am

Fanhua BluePlus and Biotecan will leverage their respective resources and service strengths to collaborate on cutting-edge medical testing, health management, cell therapy, and other modern high-end medical and health management services.

Posted In: FANH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist